[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SuperDuperDrugs Super DuperSuper Duper posts on X about $wve, $arwr, $nvo, if you the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XXXX%
Social topic influence $wve #185, $arwr #29, $nvo 6.67%, if you XXXX%
Top accounts mentioned or mentioned by @rnaianalyst @bikerieder @bioboyscout @cmaclaxatx @michaeljburry @connorsullychi @jfais20 @biomedicalrx @warrensirna @financelancelot @persimmonti @martinshkreli @bitcointeddy @avidresearch @jul05310473john @jessebrodkin @balabioresearch @bioyolo420 @3idwarrant
Top assets mentioned Wave Life Sciences Ltd. Ordinary Shares (WVE) Arrowhead Research Corporation (ARWR) Novo-Nordisk (NVO)
Top posts by engagements in the last XX hours
"@RNAiAnalyst $NVO however is positioned to be a fast follower to $WVE and $ARWR . I think $NVO is a nice long if you have INHBE conviction"
X Link 2025-12-08T13:00Z XXX followers, 1338 engagements
"No need for $WVE to present interim data in a special presentation unless its good. Great setup for $ARWR data in January as well"
X Link 2025-12-07T21:46Z XXX followers, 2912 engagements
"@Jul05310473John @jesse_brodkin Have you heard of GLP1 drugs I hear they work pretty well. When the combo therapy data comes out matching the mouse and NHP data you will understand"
X Link 2025-12-08T15:02Z XXX followers, XX engagements
"@BalaBioResearch @BioYOLO420 Someone in BP tired of the GLP1 me too game will pay for $WVE even if $ARWR has the lead with ALK7"
X Link 2025-12-08T17:47Z XXX followers, XXX engagements